These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 20838098)

  • 1. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL
    Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats.
    Grémy O; Tsapis N; Chau Q; Renault D; Abram MC; Van der Meeren A
    Radiat Res; 2010 Nov; 174(5):637-44. PubMed ID: 20726717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
    Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of wound intake of plutonium isotopes and 241Am in a human: application and improvement of the NCRP wound model.
    Schadilov AE; Belosokhov MV; Levina ES
    Health Phys; 2010 Oct; 99(4):560-7. PubMed ID: 20838099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
    Taylor DM; Hodgson SA; Stradling N
    Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
    Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
    Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of DTPA Treatment on Internal Dose Estimates.
    Davesne E; Blanchardon E; Peleau B; Correze P; Bohand S; Franck D
    Health Phys; 2016 Jun; 110(6):551-7. PubMed ID: 27115221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
    Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
    Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotopic and elemental composition of plutonium/americium oxides influence pulmonary and extra-pulmonary distribution after inhalation in rats.
    Van der Meeren A; Grémy O
    Health Phys; 2010 Sep; 99(3):380-7. PubMed ID: 20699701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting plutonium decorporation efficacy after intravenous administration of DTPA formulations: Study of pharmacokinetic-pharmacodynamic relationships in rats.
    Phan G; Le Gall B; Deverre JR; Fattal E; Bénech H
    Pharm Res; 2006 Sep; 23(9):2030-5. PubMed ID: 16951998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of orally available, amphipathic polyaminocarboxylic acid chelators for actinide decorporation.
    Miller SC; Wang X; Bowman BM
    Health Phys; 2010 Sep; 99(3):408-12. PubMed ID: 20699705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
    Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
    Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat.
    Miller SC; Liu G; Bruenger FW; Lloyd RD
    Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium.
    Gervelas C; Serandour AL; Geiger S; Grillon G; Fritsch P; Taulelle C; Le Gall B; Benech H; Deverre JR; Fattal E; Tsapis N
    J Control Release; 2007 Mar; 118(1):78-86. PubMed ID: 17241685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
    Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
    J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three plutonium chelation cases at Los Alamos National Laboratory.
    Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
    Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacies of pure LICAM(C) and DTPA on the retention of plutonium-238 and americium-241 in rats after their inhalation as nitrate and intravenous injection as citrate.
    Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A; Volf V; Taylor DM; Wirth P; Gaskin PW
    Int J Radiat Biol; 1989 Oct; 56(4):503-14. PubMed ID: 2571662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat: comparison with other siderophore analogues.
    Stradling GN; Gray SA; Ellender M; Moody JC; Hodgson A; Pearce M; Wilson I; Burgada R; Bailly T; Leroux YG
    Int J Radiat Biol; 1992 Oct; 62(4):487-97. PubMed ID: 1357063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.